Percheron Therapeutics Limited

0 followers


Percheron Therapeutics Limited (ASX: PER) is an international biotechnology company focused on the development of novel therapies for rare diseases. The company’s lead program is ATL1102, an antisense oligonucleotide targeting the CD49d receptor. ATL1102 is currently the subject of an ongoing inte... Read more

Headquarters

Melbourne, AU

Employees

1-10

Links

Org chart

Dr. James Garner

Collapse
Andrew McKenzie
Clinical Development Director
Anthony Filippis
Chief Operating Officer
George Tachas
Principal Scientist
Charmaine Gittleson
Non Executive Board Director
Gil Price
Member Board Of Directors, Audit Chair

Teams

This company has no teams yet